DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global In Vitro Diagnostics (IVD) Market by Technology (Immunodiagnostics, Molecular Diagnostics, Clinical Chemistry) and by Product Type (Reagents, Instrument Services and Instrumentation) Outlook 2020" report to their offering.
The global IVD Market was valued at US$ 54.7 billion in the year 2015 and is expected to reach to US$ 71.8 billion by the end of the year 2020. Growth of the industry is driven by increasing prevalence of chronic and infectious diseases, growing geriatric population, implementation of the Affordable Care Act (ACA) and rise in demand for Point of Care facilities.
However, complex regulatory framework and cumbersome reimbursement policy are the major factors restraining the growth of IVD industry. Key trends prevailing in the industry includes VC funding & IPOs in IVD Market , Point-of-care (POC) Molecular test products and emergence of Targeted Genomic Therapies .
IVD market is segmented into various categories based on product type, test location, discipline and application. The market by products is broadly categorized into Reagents, Instrumentation and Instrument Services. Based on test location, the market is segmented into Central Laboratory Testing, Point of Care and OTC/ Self-testing. In terms of technological segmentation, IVD can be broadly classified into categories such as Immuno assay, Clinical Chemistry, Molecular Diagnostics, Hematology, Point of Care and Microbiology.
- Abbott Laboratories
- Roche Holding AG
- Siemens AG
Key Topics Covered:
1. Executive Summary
2. Research Methodology
3. In Vitro Diagnostics
4. IVD Market Segmentation
5. Global In Vitro Diagnostics (IVD) Market Segmentation
6. Global In Vitro Diagnostics (IVD) Market Regional Analysis
7. Market Dynamics
8. Global IVD Market Trends
9. Competitive Landscape
10. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/2sqtck/global_in_vitro